Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Oral treprostinil (UT-15C) Sustained Release Tablets[1] Treprostinil[1] D06213 [1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86
2UT-15C----[1] 86
3UT-15C (treprostinil diethanolamine)[1] Treprostinil[1] D06213 [1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86
4UT-15C 0.25 mg----[1] 86
5UT-15C 1 mg----[1] 86
6UT-15C 5 mg----[1] 86
7UT-15C LP----[1] 86
8UT-15C SR----[2] 51, 86
9UT-15C SR (treprostinil diethanolamine)[1] Treprostinil[1] D06213 [1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86
10UT-15C-SR----[2] 51, 86